Atrium Innovations names Peter Luther President and CEO

Former President of Johnson & Johnson Consumer Healthcare to lead Atrium\'s accelerated expansion

Atrium Innovations, a leader in the development, manufacturing and commercialisation of innovative, science-based natural health products, has named Peter Luther, former President of Johnson & Johnson Consumer Healthcare, as President and Chief Executive Officer of Atrium, effective at the end of June. He succeeds Pierre Fitzgibbon, who will leave the company by mutual agreement with the Board of Directors.

The company also announced that Jacques Bougie, former President and CEO of Alcan, W. Brian Edwards, founder and former CEO of BCE Emergis, and Luther will join Atrium's Board of Directors. Bougie will serve as Chairman of the Board and be based in Montreal, Québec, Canada.

Luther has 25 years of experience in the consumer packaged goods and healthcare industries. Since 1987, he has worked for Johnson & Johnson and has served as President of several of the company's large divisions over the past 10+ years. His most recent role was President of the Consumer Healthcare business.

“I'm honoured to have been selected to serve as Atrium's next CEO and am excited by the potential of this impressive company,” said Luther. “I see tremendous opportunities to build on Atrium's product portfolio and advance commercialisation and global distribution while upholding the company's unwavering commitment to high quality products that improve people's lives.”

Bougie was the President and CEO of Alcan, a Québec-based global aluminium producer and packaging products supplier, from 1993 to 2001. In this role, he spearheaded the greatest expansion in the company's history through its acquisition of AluSuisse in 2000 and laid the groundwork for the acquisition of the French group Péchiney in 2004. Before serving as CEO, he was President and COO of Alcan from 1989 to 1993.

Edwards is the founder and former CEO of BCE Emergis, one of North America's most successful electronic commerce companies. Under his leadership from 1988 to 2002, the company grew from a small start-up to a company with revenues of more than $650m and more than 2,000 employees.

You may also like

Finance

Nestlé extends consumer healthcare portfolio by agreeing to acquire Atrium Innovations

The transaction is expected to close in the first quarter of 2018 following the completion of customary approvals and closing conditions
Ingredients

Swedencare's dog soft chew, ProDen PlaqueOff, gains Vetinary Oral Health Council seal of approval

The supplement, which contains Swedencare's A.N ProDen seaweed ingredient, is designed to control plaque and tartar in dogs
Ingredients

Omega-3 and omega-6 intake could reduce a person's risk of developing cancer, study finds

Higher intake of both omega-3 and omega-6 can reduce an individual's risk of 19 different cancers, though this impact varied based on sex and age and omega-3/6 ratios
Manufacturing

Happy Plant Protein secures €1.8m to develop and license its plant-based protein ingredients

The manufacturing process developed by Happy Plant Protein can reduce plant-based protein production costs by up to 90%, while also creating functional food products with a 70–80% protein content
Training & Education

Gnosis by Lesaffre's Vitamin K2 Scientific Advisory Committee share this year's findings

In the K2SAC's third meeting, experts discussed the potential of vitamin K2 in healthy ageing and cognitive health, while also looking at necessary future endeavours
Ingredients

Vitamins B and E may assist in staving off age-related macular degeneration, study finds

Those who had higher intakes of vitamin E, B1, B2, B6, B12 and folic acid, were less likely to develop AMD
Ingredients

Vitamin K2, vitamin D3 and magnesium prove popular as a combo in global consumer survey

A European consumer survey involving participants from Germany, Italy and the UK reveals a notable interest in the nutraceutical combination
Subscribe now